China Resources Boya Bio-pharmaceutical Group Co.,Ltd

SZSE:300294 Stock Report

Market Cap: CN¥15.4b

China Resources Boya Bio-pharmaceutical GroupLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Xiaoming Liang

Chief executive officer

CN¥4.0m

Total compensation

CEO salary percentagen/a
CEO tenure3.8yrs
CEO ownershipn/a
Management average tenure3.3yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

Investors Can Find Comfort In China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Earnings Quality

Nov 01
Investors Can Find Comfort In China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Earnings Quality

A Look At The Intrinsic Value Of China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)

Oct 01
A Look At The Intrinsic Value Of China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)

Market Participants Recognise China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) Earnings

Sep 12
Market Participants Recognise China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) Earnings

Does China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Have A Healthy Balance Sheet?

Jul 25
Does China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Have A Healthy Balance Sheet?

China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) P/E Is On The Mark

Jun 12
China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) P/E Is On The Mark

China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Is Increasing Its Dividend To CN¥0.30

Apr 26
China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Is Increasing Its Dividend To CN¥0.30

Is China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Using Too Much Debt?

Apr 22
Is China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Using Too Much Debt?

China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Conservative Accounting Might Explain Soft Earnings

Apr 01
China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Conservative Accounting Might Explain Soft Earnings

What Does The Future Hold For China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)? These Analysts Have Been Cutting Their Estimates

Mar 31
What Does The Future Hold For China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)? These Analysts Have Been Cutting Their Estimates

CEO

Xiaoming Liang (57 yo)

3.8yrs

Tenure

CN¥4,017,400

Compensation

Mr. Xiaoming Liang serves as Non-Independent Director at Boya Bio-pharmaceutical Group Co., Ltd since February 03, 2021 and also serves as a President. He is a member of the first session of the Biotechnol...


Leadership Team

NamePositionTenureCompensationOwnership
Xiaoming Liang
President & Directorno dataCN¥4.02mno data
Huacheng Liang
VP, CFO2.9yrsCN¥1.69mno data
Bing Chen
Vice President3.8yrsCN¥6.54m0.014%
CN¥ 2.2m
Shousun Ii
Vice President3.8yrsCN¥2.48mno data
Shuanhong Zhang
Vice President2.3yrsCN¥1.27mno data

3.3yrs

Average Tenure

47yo

Average Age

Experienced Management: 300294's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Xiaoming Liang
President & Director3.8yrsCN¥4.02mno data
Huacheng Liang
VP, CFO2.9yrsCN¥1.69mno data
Shao Shao
Supervisorno datano datano data
Na Tang
Chairman of Supervisory Board2.9yrsno datano data
Guiling Tan
Non-Employee Representative Supervisor7.7yrsno datano data
Weidong Zhang
Independent Director3.8yrsCN¥200.00kno data
Huasheng Huang
Independent Director3.8yrsCN¥200.00kno data
Li Zhao
Independent Director3.8yrsCN¥200.00kno data
Kai Qiu
Chairman of the Board1.1yrsno datano data
Jinfeng Shen
Director1.1yrsno datano data
Jinni Sun
Directorless than a yearno datano data
Yuxuan Pan
Directorless than a yearno datano data

2.9yrs

Average Tenure

54yo

Average Age

Experienced Board: 300294's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.